The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 35, Issue 1, Pages 1-10
Publisher
Springer Nature
Online
2013-12-09
DOI
10.1038/aps.2013.131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- ABCG2: recent discovery of potent and highly selective inhibitors
- (2013) Florine Lecerf-Schmidt et al. Future Medicinal Chemistry
- Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy
- (2013) M. Tiribelli et al. HAEMATOLOGICA
- Expression ofSLC22A1variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib
- (2013) Elisa Herraez et al. HEPATOLOGY
- IMP3 Protein Promotes Chemoresistance in Breast Cancer Cells by Regulating Breast Cancer Resistance Protein (ABCG2) Expression
- (2013) Sanjoy Samanta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The ABCs of membrane transporters in health and disease (SLC series): Introduction
- (2013) Matthias A. Hediger et al. MOLECULAR ASPECTS OF MEDICINE
- Influence of Cytochrome P450 2C19 Gene Variations on Pharmacokinetic Parameters of Thalidomide in Japanese Patients
- (2012) Naoki Matsuzawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia
- (2012) A. Giannoudis et al. BLOOD
- Overcoming nucleoside analog chemoresistance of pancreatic cancer: A therapeutic challenge
- (2012) Sau Wai Hung et al. CANCER LETTERS
- The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells
- (2012) Annemarie Losert et al. CANCER LETTERS
- Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy
- (2012) M. T. Kuo et al. CANCER RESEARCH
- Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
- (2012) J. J.G. Marin et al. CURRENT CANCER DRUG TARGETS
- A comprehensive study of polymorphisms inABCB1, ABCC2andABCG2and lung cancer chemotherapy response and prognosis
- (2012) Daniele Campa et al. INTERNATIONAL JOURNAL OF CANCER
- No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
- (2012) P. Martinez-Becerra et al. MOLECULAR PHARMACEUTICS
- Cisplatin-Induced Chemoresistance in Colon Cancer Cells Involves FXR-Dependent and FXR-Independent Up-Regulation of ABC Proteins
- (2012) Elisa Herraez et al. MOLECULAR PHARMACEUTICS
- Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients
- (2012) Ji-Ye Yin et al. PLoS One
- Genetic Variants in Oxidative Stress-Related Genes Predict Chemoresistance in Primary Breast Cancer: A Prospective Observational Study and Validation
- (2011) K.-D. Yu et al. CANCER RESEARCH
- Pharmacokinetic Impact of SLCO1A2 Polymorphisms on Imatinib Disposition in Patients With Chronic Myeloid Leukemia
- (2011) Y Yamakawa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia
- (2011) M Ansari et al. PHARMACOGENOMICS JOURNAL
- DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
- (2011) Elke Schaeffeler et al. Genome Medicine
- Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin
- (2010) Gabriele Buda et al. ANNALS OF HEMATOLOGY
- ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma
- (2010) T. Mizuno et al. ANNALS OF ONCOLOGY
- The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number
- (2010) J. Gregers et al. BLOOD
- Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
- (2010) J. Marin et al. CURRENT MEDICINAL CHEMISTRY
- Strategies for Overcoming Chemotherapy Resistance in Enterohepatic Tumours
- (2010) J.J.G. Marin et al. CURRENT MOLECULAR MEDICINE
- Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas
- (2010) S. Rau et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer
- (2010) Ewa Balcerczak et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia
- (2010) Margherita Maffioli et al. LEUKEMIA RESEARCH
- Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia
- (2010) Ling-Na Ni et al. MEDICAL ONCOLOGY
- Expression of MRP1 gene in acute leukemia
- (2010) Frouzandeh Mahjoubi et al. Sao Paulo Medical Journal
- Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma
- (2010) Jing Zhao WORLD JOURNAL OF GASTROENTEROLOGY
- A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
- (2009) King Leung Fung et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia
- (2009) M. Ansari et al. BLOOD
- MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
- (2009) Ning Sun et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
- (2009) D. H. Kim et al. CLINICAL CANCER RESEARCH
- Association of the c.3972C>T Variant of the Multidrug Resistance-Associated Protein 2 Gene (MRP2/ABCC2) with Susceptibility to Bile Duct Cancer
- (2009) A. Höblinger et al. DIGESTION
- Hepatobiliary transporters in the pharmacology and toxicology of anticancer drugs
- (2009) Jose et al. Frontiers in Bioscience-Landmark
- Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment
- (2009) Cristina Rodriguez-Antona et al. HUMAN GENETICS
- Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: Emerging roles
- (2009) Sharon La Fontaine et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer
- (2009) Mariusz Panczyk et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Polymorphisms inABCG2,ABCC3andCNT1genes and their possible impact on chemotherapy outcome of lung cancer patients
- (2008) Phillip J. Müller et al. INTERNATIONAL JOURNAL OF CANCER
- Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups
- (2008) Phillip Müller et al. LEUKEMIA RESEARCH
- NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
- (2008) Rainer Fagerholm et al. NATURE GENETICS
- ABCB1 G1199A Polymorphism and Ovarian Cancer Response to Paclitaxel
- (2007) Henrik Gréen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started